Volume : 11, Issue : 05, May – 2024
Title:
EFFECTS OF INTERMITTENT FASTING ON METABOLISM IN INDIVIDUALS WITH TYPE II DIABETES MELLITUS
Authors :
Ramy Abdallah , Badriah Alharbi , Fai Aljahdali , Alaa Alzahrani , Ahmed Alaqqad
Abstract :
Background: For obese people, intermittent fasting (IF) has been suggested as a weight-loss method with extra cardiometabolic advantages. It’s still unknown how IF affects people with type 2 diabetes (T2DM), despite its increasing popularity. Aim :In order to assess the metabolic effects of IF in relation to the conventional diet in individuals with type 2 diabetes, we carried out a systematic review and meta-analysis. Method: Between 1950 and August 12, 2020, randomised, diet-controlled trials assessing any IF intervention in individuals with T2DM were sought after using Embase, PubMed, and clinicaltrials.gov. Using a random-effects model to calculate pooled estimates of the absolute changes in body weight and glycated hemoglobin A1c (HbA1c) compared to a control group, we investigated the effects of IF on weight reduction and glucose-lowering. Results: Our inclusion criteria were met by seven studies (n = 338 participants; mean baseline HbA1c 8.8%, mean body mass index [BMI] 35.65). Compared to a conventional diet, IF caused a larger drop in body weight of -1.89 kg (95% CI, -2.91 to -0.86 kg), with no discernible between-study heterogeneity (I2 21.0%, P =.28). Studies with a heavier population (BMI > 36) showed a significant extra weight reduction as did studies with a shorter duration (≤ 4 months) .When compared to a conventional diet, IF did not result in a higher decrease in HbA1c Conclusion: According to available data, individuals with type 2 diabetes may lose more weight when following an IF diet as opposed to a conventional diet, while also experiencing comparable improvements in glycemic control.
Key words: Glycated hemoglobin, body weight, type 2 diabetes, and intermittent fasting
Cite This Article:
Please cite this article in press Ramy Abdallah et al., Effects Of Intermittent Fasting On Metabolism In Individuals With Type Ii Diabetes Mellitus., Indo Am. J. P. Sci, 2024; 11 (05).
Number of Downloads : 10
References:
1. Janssen I . The public health burden of obesity in Canada. Can J Diabetes.2013;37(2):90-96.
2. Kramer CK , Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med.2013;159(11):758-769.
3. Khalangot M , Tronko M, Kravchenko V, Kulchinska J, Hu G. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine. Heart.2009;95(6):454-460.
4. McEwen LN , Kim C, Karter AJ, et al. Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care.2007;30(7):1736-1741.
5. Zhao W , Katzmarzyk PT, Horswell R, et al. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation.2014;130(24):2143-2151.
6. Franz MJ , Boucher JL, Rutten-Ramos S, VanWormer JJ. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet.2015;115(9):1447-1463.
7. Tinsley GM , La Bounty PM. Effects of intermittent fasting on body composition and clinical health markers in humans. Nutr Rev.2015;73(10):661-674.
8. Heilbronn LK , Civitarese AE, Bogacka I, Smith SR, Hulver M, Ravussin E. Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obes Res.2005;13(3):574-581.
9. Varady KA , Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr.2009;90(5):1138-1143.
10. Bhutani S , Klempel MC, Berger RA, Varady KA. Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations. Obesity (Silver Spring).2010;18(11):2152-2159.
11. Varady KA , Bhutani S, Klempel MC, Lamarche B. Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults. Br J Nutr.2011;105(4): 580-583.
12. Klempel MC , Kroeger CM, Varady KA. Alternate day fasting increases LDL particle size independently of dietary fat content in obese humans. Eur J Clin Nutr.2013;67(7):783-785.
13. Klempel MC , Kroeger CM, Bhutani S, Trepanowski JF, Varady KA. Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women. Nutr J.2012;11:98.
14. Carlson O , Martin B, Stote KS, et al. Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. Metabolism.2007;56(12):1729-1734.
15. Stote KS , Baer DJ, Spears K, et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr.2007;85(4):981-988.
16. Tinsley GM , Forsse JS, Butler NK, et al. Time-restricted feeding in young men performing resistance training: a randomized controlled trial. Eur J Sport Sci.2017;17(2):200-207.
17. Tsai AG , Wadden TA. The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring).2006;14(8):1283-1293.
18. Horne BD , Grajower MM, Anderson JL. Limited evidence for the health effects and safety of intermittent fasting among patients with type 2 diabetes. Jama.2020;324(4):341-342.
19. Furmli S , Elmasry R, Ramos M, Fung J. Therapeutic use of intermittent fasting for people with type 2 diabetes as an alternative to insulin. BMJ Case Rep.2018;2018:bcr2017221854.
20. Corley BT , Carroll RW, Hall RM, Weatherall M, Parry-Strong A, Krebs JD. Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med.2018;35(5):588-594.
21. Carter S , Clifton PM, Keogh JB. Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial. JAMA Netw Open.2018;1(3):e180756.
22. Williams KV , Mullen ML, Kelley DE, Wing RR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care.1998;21(1):2-8.
23. Wing RR , Blair E, Marcus M, Epstein LH, Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?Am J Med.1994;97(4):354-362.
24. Moher D , Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med.2009;151(4):264-269, W64.
25. Higgins JP , Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med.2002;21(11):1539-1558.
26. Kahleova H , Belinova L, Malinska H, et al. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study. Diabetologia.2014;57(8):1552-1560.
27. Begg CB , Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics.1994;50(4):1088-1101.
Google ScholarCrossrefPubMedWorldCat
28. Duval S , Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics.2000;56(2):455-463.
29. Wing RR , Marcus MD, Salata R, Epstein LH, Miaskiewicz S, Blair EH. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med.1991;151(7):1334-1340.
30. Paisey RB , Frost J, Harvey P, et al. Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet.2002;15(2):121-127.
31. Li C , Sadraie B, Steckhan N, et al. Effects of a one-week fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome—a randomized controlled explorative study. Exp Clin Endocrinol Diabetes.2017;125(9):618-624.
32. Pi-Sunyer X , Blackburn G, Brancati FL, et al. ; Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care.2007;30(6):1374-1383.
33. Nagelkerk J , Reick K, Meengs L. Perceived barriers and effective strategies to diabetes self-management. J Adv Nurs.2006;54(2):151-158.
34. Jonker JT , Snel M, Hammer S, et al. Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus patients. Int J Cardiovasc Imaging.2014;30(1):121-127.
35. Snel M , Jonker JT, Hammer S, et al. Long-term beneficial effect of a 16-week very low calorie diet on pericardial fat in obese type 2 diabetes mellitus patients. Obesity (Silver Spring).2012;20(8):1572-1576.
36. Teeuwisse WM , Widya RL, Paulides M, et al. Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes. Diabetes.2012;61(12):3255-3259.
37. Steven S , Hollingsworth KG, Al-Mrabeh A, et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care.2016;39(5):808-815.
38. Berk KA , Mulder MT, Verhoeven AJ, et al. Predictors of diet-induced weight loss in overweight adults with type 2 diabetes. PLoS One.2016;11(8):e0160774.
39. Hammer S , Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol.2008;52(12):1006-1012.
40. Wang Y , Snel M, Jonker JT, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL. Diabetes Care.2011;34(12):2576-2580.
41. Dhindsa P , Scott AR, Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med.2003;20(4):319-324.
42. Capstick F , Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract.1997;36(2):105-111.
43. Anton SD , Moehl K, Donahoo WT, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity (Silver Spring).2018;26(2):254-268.
44. Sutton EF , Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab.2018;27(6):1212-1221.e3.
45. de Cabo R , Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med.2019;381(26):2541-2551.